Nanoclay-Mediated Crystal-Phase Engineering in Biofunctions to Balance Antibacteriality and Cytotoxicity.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 39873319.
- Also identified by DOI 10.1021/acs.nanolett.4c05691.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The crystalline phase of metal oxides is a key determinant of the properties and functions of the nanomaterials. Traditional approaches have focused on replicating bulk-phase structures, with limited exploration of phase diversity due to challenges in controlling the crystal morphology. Here, we introduce a nanoclay-mediated strategy for crystal-phase engineering, using talc to modulate the morphology and phase of manganese oxide (MnOx) nanoparticles. This approach enhances the oxidase activity of the MnOx composite (M/T), optimizing the antimicrobial efficacy while minimizing cytotoxicity. M/T-190 demonstrated 99% bactericidal activity against <i>Escherichia coli</i> and <i>Staphylococcus aureus</i>, coupled with 84% cytocompatibility. Theory calculations suggest that talc modulates the charge distribution and d-band center tuning at the Mn<sub>3</sub>O<sub>4</sub>/MnOOH interface, enhancing oxygen activation. When integrated into gauze, M/T exhibits strong antimicrobial activity, low toxicity, and promotes wound healing in both in vitro and in vivo studies. These findings highlight the potential of natural minerals for crystal-phase engineering in biomedical applications.
Medical subject headings
- Anti-Bacterial Agents
- Oxides
- Manganese Compounds
- Clay